1. Home
  2. WFC vs MRK Comparison

WFC vs MRK Comparison

Compare WFC & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wells Fargo & Company

WFC

Wells Fargo & Company

HOLD

Current Price

$79.40

Market Cap

246.0B

Sector

Finance

ML Signal

HOLD

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

HOLD

Current Price

$111.85

Market Cap

268.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WFC
MRK
Founded
1852
2000
Country
United States
United States
Employees
205000
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
246.0B
268.7B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
WFC
MRK
Price
$79.40
$111.85
Analyst Decision
Buy
Buy
Analyst Count
18
17
Target Price
$96.59
$125.59
AVG Volume (30 Days)
12.9M
7.3M
Earning Date
04-14-2026
04-30-2026
Dividend Yield
2.24%
2.97%
EPS Growth
N/A
8.01
EPS
N/A
7.28
Revenue
N/A
$65,011,000,000.00
Revenue This Year
$11.08
$3.61
Revenue Next Year
$4.76
$5.41
P/E Ratio
$14.15
$15.78
Revenue Growth
N/A
1.31
52 Week Low
$68.67
$75.40
52 Week High
$97.76
$125.14

Technical Indicators

Market Signals
Indicator
WFC
MRK
Relative Strength Index (RSI) 43.29 37.97
Support Level $77.23 $105.23
Resistance Level $79.72 $112.44
Average True Range (ATR) 1.66 2.99
MACD -0.24 -0.95
Stochastic Oscillator 2.15 2.80

Price Performance

Historical Comparison
WFC
MRK

About WFC Wells Fargo & Company

Wells Fargo is a premier, North American-focused banking titan that commands a $2.2 trillion balance sheet and the third-highest deposit market share in the United States. The bank uses a dense, expansive network of 4,093 branches to champion retail consumers and the middle market, where the firm has built a particularly strong reputation. Following the removal of its federal asset cap in 2025, the firm is set to deploy its legacy excess liquidity to expand each of its four segments: consumer & business lending, commercial banking, corporate & investment banking, and wealth & investment management.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Share on Social Networks: